Catapres
Product Images NDC 21695-567

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Catapres (NDC 21695-567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Catapres (clonidine) (F4ac82b0 D0fb 4720 A277 5b2b8013cb3f 01)

Chemical structure of clonidine showing a dichlorophenyl group linked to an imidazoline ring, consistent with the active ingredient in Catapres.*

FDA Label Image

Figure 6 (F4ac82b0 D0fb 4720 A277 5b2b8013cb3f 02)

An illustration showing the cross-sectional layers of a transdermal patch. The layers from top to bottom are labeled as Backing, Drug Reservoir, Control Membrane, Adhesive, and Slit Release Liner.*

FDA Label Image

Figure 1 (F4ac82b0 D0fb 4720 A277 5b2b8013cb3f 03)

An instructional diagram showing the placement of an adhesive cover over a medical patch on a person's upper arm. The patch is clearly labeled, and the adhesive cover is indicated as optional to secure the patch if necessary. This figure provides visual guidance for proper application.*

FDA Label Image

Figure 2 (F4ac82b0 D0fb 4720 A277 5b2b8013cb3f 04)

An instructional diagram displaying two types of pouches in a Catapres-TTS box. The first pouch contains the medication patch, labeled as Catapres-TTS, and the second pouch contains an adhesive cover to be used if the patch becomes loose. Each pouch is shown clearly with instructions for proper use.*

FDA Label Image

Figure 3 (F4ac82b0 D0fb 4720 A277 5b2b8013cb3f 05)

An instructional black-and-white illustration showing hands using a medical device or product application method. The image is labeled as Figure 3 and appears to demonstrate a step in handling or applying the Catapres product from Rebel Distributors Corp.*

FDA Label Image

Figure 4 (F4ac82b0 D0fb 4720 A277 5b2b8013cb3f 06)

An instructional illustration depicting hands assembling or handling a small component, possibly for a medical or pharmaceutical device. The image shows detailed finger positioning on the component, suggesting a step in a usage or preparation process.*

FDA Label Image

Figure 5 (F4ac82b0 D0fb 4720 A277 5b2b8013cb3f 07)

An instructional anatomical illustration labeled Figure 5, showing a hand positioned to indicate injection into the upper arm muscle, demonstrating the proper site for an intramuscular injection.*

FDA Label Image

Figure 6 (F4ac82b0 D0fb 4720 A277 5b2b8013cb3f 08)

Packaging label for Catapres patch by Rebel Distributors Corp with a tamper-evident adhesive cover. The label warns that the cover does not contain active medication and instructs to apply the patch if necessary, directing users to patient instructions for application.*

FDA Label Image

Catapres Tts 0.1mg (F4ac82b0 D0fb 4720 A277 5b2b8013cb3f 09)

Catapres TTS 0.1mg patches packaging label from Rebel Distributors Corp showing 1x4 patches. Each patch contains 0.1mg Clonidine. The label includes NDC 21695-567-04 and distribution information for Physician Partner, Thousand Oaks, CA. Storage instructions note controlled room temperature 15-30°C (59-86°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.